SCHEMBL9748588

SCHEMBL9748588

CCCCCCCCCCCCCCCC(=O)Nc1c2c(nc3ccccc13)CCCC2

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.66
GAA P10253 2/20 0.66
ALDH1A1 P00352 2/20 0.66
HPGD P15428 1/20 0.66
BCHE P06276 4/20 0.59
ACHE P22303 4/20 0.59
HTT P42858 1/20 0.59
MAPT P10636 1/20 0.58
GABRP O00591 1/20 0.57
GABRD O14764 1/20 0.57
APP P05067 1/20 0.57
GABRA1 P14867 1/20 0.57
GABRB1 P18505 1/20 0.57
GABRG2 P18507 1/20 0.57
GABRB3 P28472 1/20 0.57
GABRA5 P31644 1/20 0.57
GABRA3 P34903 1/20 0.57
GABRA2 P47869 1/20 0.57
GABRB2 P47870 1/20 0.57
GABRA4 P48169 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8443211 1.00 KDM4E (0.66) KDM4EGAAALDH1A1HPGDBCHE
SCHEMBL9747358 0.95 KDM4E (0.63) KDM4EGAAALDH1A1HPGDBCHE
SCHEMBL9387187 0.92 KDM4E (0.69) KDM4EGAAALDH1A1BCHEACHE
SCHEMBL27524922 0.87 BCHE (0.63) KDM4EGAABCHEACHEHTT
SCHEMBL9748781 0.86 KDM4E (0.68) KDM4EGAAALDH1A1BCHEACHE
SCHEMBL8474173 0.82 BCHE (0.66) KDM4EGAABCHEACHEHTT
SCHEMBL9384234 0.81 KDM4E (0.72) KDM4EGAAALDH1A1BCHEACHE
SCHEMBL9382159 0.81 KDM4E (0.65) KDM4EGAAALDH1A1BCHEACHE
SCHEMBL8523769 0.81 KDM4E (0.62) KDM4EGAAALDH1A1BCHEACHE
SCHEMBL9232310 0.81 KDM4E (0.64) KDM4EGAAALDH1A1BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175172-A Administering amino-1,2,3,4-tetrahydroacridine and derivatives for elevation of T4 lymphocytes level in patients DIETLIN FRANCOIS (FR) 1992-12-29 US disclosed